UnitedHealth Group (UNH) closed the most recent trading day at $506.10, moving -0.05% from the previous trading session.
The latest trading day saw UnitedHealth Group (UNH) settling at $506.34, representing a +1.24% change from its previous close.
UnitedHealth Group's recent price pullback presents a buying opportunity for long-term dividend growth investors, despite the CEO's death and short-term volatility. Strong fundamentals: Q3 earnings beat estimates with EPS of $7.15 and revenue at $100.8 billion, showing robust top and bottom line growth. Sustainable dividend growth: Dividend increased by 11.70%, supported by strong cash flows and a solid balance sheet with $32.4 billion in cash.
The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.
UnitedHealth Group (UNH) shares have been on the decline since the CEO of its UnitedHealthcare unit was killed in New York City on Dec. 4.
UNH faces challenges such as rising medical costs and regulatory pressures. However, it boasts robust cash flow and consistent dividend growth.
CappThesis founder & president Frank Cappelleri explains why a potential rebound in shares of UnitedHealth can be tied to the fortunes of Boeing's stock.
The stock price of the health insurer has tumbled 21% since a top executive was murdered on Dec. 4.
Manhattan's district attorney hosts a news conference to give the latest update on the UnitedHealthcare CEO shooting.
Sarat Sethi, DCLA managing partner, joins 'Power Lunch' to discuss stock plays for three stocks.
Shares in major healthcare companies fell yesterday after president-elect Donald Trump made comments that he wanted to “knock out” prescription drug industry middlemen. The fall makes this yet another week since the killing of UnitedHealth CEO Brian Thompson that the business practices of companies that operate America's private healthcare system have come under increased scrutiny.
Health insurance companies have been in the limelight lately after the shooting of Brian Thompson, the CEO of the medical insurance arm of UNH. Furthermore, a news report suggesting that a bipartisan group of lawmakers may introduce legislation to force health insurance companies to divest their pharmacy business has raised concerns among investors.